June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Development of Artificial Intelligence for diagnosis of nuclear cataract in the Non-mydriasis eyes: Efficiency as a screening tool?
Author Affiliations & Notes
  • Eisuke Shimizu
    OUI Inc., Japan
    Yokohama Keiai Eye Clinic, Japan
  • Makoto Tanji
    OUI Inc., Japan
  • Shintaro Nakayama
    OUI Inc., Japan
  • Toshiki Ishikawa
    OUI Inc., Japan
  • Naomichi Agata
    OUI Inc., Japan
  • Yo Nakahara
    OUI Inc., Japan
  • Ryota Yokoiwa
    OUI Inc., Japan
  • Shinri Sato
    Yokohama Keiai Eye Clinic, Japan
  • Footnotes
    Commercial Relationships   Eisuke Shimizu Japan Agency for Medical Research and Development, Code F (Financial Support); Makoto Tanji None; Shintaro Nakayama None; Toshiki Ishikawa None; Naomichi Agata None; Yo Nakahara None; Ryota Yokoiwa None; Shinri Sato None
  • Footnotes
    Support  Japan Agency for Medical Research and Development
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 3413. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Eisuke Shimizu, Makoto Tanji, Shintaro Nakayama, Toshiki Ishikawa, Naomichi Agata, Yo Nakahara, Ryota Yokoiwa, Shinri Sato; Development of Artificial Intelligence for diagnosis of nuclear cataract in the Non-mydriasis eyes: Efficiency as a screening tool?. Invest. Ophthalmol. Vis. Sci. 2023;64(8):3413.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Cataract diagnosis is performed by ophthalmologists using a slit-lamp microscope. Non-ophthalmologists is difficult to screen out cataracts because they do not have any slit-lamp instruments or experience to make a diagnosis of cataracts. In general, diagnostic imaging is compatible with artificial intelligence (AI), and AI is used as a diagnostic aid tool in radiological imaging and endoscopic imaging. Currently, in ophthalmology, diagnostic AI is being actively developed mainly for fundus diseases such as fundus photography and optical coherence tomography, but not for the cataract especially using anterior segment images. We developed a user-friendly handheld slit-lamp medical device that is able to diagnose cataracts as a conventional slit-lamp microscope. Moreover, this device is a smartphone attachment so that it can record and send anterior-segment videos. We collected the anterior-segment videos and developed cataract diagnostic AI algorithms in order to use them as a screening tool for cataracts.

Methods :
This retrospective study is conducted with the approval of the Minami Aoyama Eye Clinic Ethical Review Committee (Approval No. 202101). We gathered retrospective anterior segment datasets of 835 retrospective cases, and 141,326 frames using a hand-held slit-lamp microscope (Smart Eye Camera; OUI Inc. Tokyo Japan).
After the pre-process which eliminates insufficient images, the extracted images were evaluated for nuclear cataract severity classification by multiple ophthalmologists (Annotation by WHO classification). The annotated data were divided into training (9,618 frames) and test datasets (3,931 frames), and the training dataset was used for machine learning. The test dataset was used for evaluation.

Results : The nuclear cataract diagnosis algorithm, developed by machine learning, was analyzed on the test dataset and resulted in an accuracy of 92.9% (95% Confidence Intervals; CI 88.2-95.6%), a sensitivity of 95.8%(95%CI 91.5-98.1%), and specificity of 89.3% (95%CI 83.9-92.3%) for the diagnosis of nuclear cataract.

Conclusions :

The AI-based, nuclear cataract diagnosis algorithm successfully diagnosed cataracts with high performance compared to ophthalmologist diagnosis in Non-mydriasis eyes. With its high sensitivity, it may use in a screening where the ophthalmologist did not exist.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×